Pharmaceuticals, Biotechnology and Life Sciences
NICE has recommended the use of Takhzyro subcutaneous injection as an option for preventing recurrent attacks of hereditary angioedema (HAE) in people aged 12 and older, within their final appraisal document (FAD), Takeda UK said in a press release Wednesday.
Onxeo said it stabilized disease without tumor progression for two of the three treated patients who are still receiving treatment with AsiDNA™ plus carboplatin, with reaching satisfactory tolerance allowing the continuation of the study to evaluate AsiDNA™ in combination with carboplatin and paclitaxel, a reference treatment protocol for many cancers.
Versantis has closed a series B financing round, and plans to use the funds to fuel the completion of ongoing Phase 1b studies with VS-01 and advance its clinical development up to clinical proof-of-efficacy (phase 2a) in 2 indications.
Schreiner MediPharm has launched a new tamper-evident security concept for luer-lock syringes: Cap-Lock features a combination of a cap adapter and label that firmly seals prefilled syringes and reliably indicates any first opening.
Induction of Antigen-Specific Immune Tolerance Using Proprietary Technology Represents Novel, Targeted Treatment Modality for Autoimmune Diseases CAMBRIDGE, Mass. & LAUSANNE,…
Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, has successfully completed patient recruitment in its study called Restore.
Roche’s study met a goal, comparing a lung cancer therapy Tecentriq with cisplatin and pemetrexed as the initial monotherapy compared in advanced non-squamous and squamous non-small cell lung cancer (NSCLC) without ALK or EGFR mutations (Wild-Type or WT).
LUGANO, Switzerland–(BUSINESS WIRE)–Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn…
Eligible patients in Scotland will immediately have access to ORKAMBI (lumacaftor/ivacaftor) and SYMKEVI (tezacaftor/ivacaftor) in combination with ivacaftor
ST GALLEN, Switzerland–(BUSINESS WIRE)–Regulatory News: Vifor Pharma today announced changes to its management. Dr Klaus Henning Jensen will join the…